Shinichi Tsujimoto

Yokohama, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications

Multi-omics analysis of pediatric minimally differentiated acute myeloid leukemia reveals RUNX1-driven stemness and chemoresistance.

Multi-omics analysis of pediatric minimally differentiated acute myeloid leukemia reveals RUNX1-driven stemness and chemoresistance.

Journal: Leukemia
Published: November 01, 2025

Identification of cellular hierarchy in paediatric acute myeloid leukaemia: The Japan Children's Cancer Group trial (JCCG AML-12).

Identification of cellular hierarchy in paediatric acute myeloid leukaemia: The Japan Children's Cancer Group trial (JCCG AML-12).

Journal: British journal of haematology
Published: September 12, 2025

Age-specific mutation profiles and their prognostic implications in pediatric KMT2A-rearranged acute myeloid leukemia.

Age-specific mutation profiles and their prognostic implications in pediatric KMT2A-rearranged acute myeloid leukemia.

Journal: Haematologica
Published: June 15, 2025

Genomic Profiling of Pediatric Solid Tumors With a Dual DNA/RNA Panel: JCCG-TOP2 Study.

Genomic Profiling of Pediatric Solid Tumors With a Dual DNA/RNA Panel: JCCG-TOP2 Study.

Journal: Cancer science
Published: May 08, 2025

Primary intracranial sarcoma associated with DICER1 mutant: a case report and preclinical investigation.

Primary intracranial sarcoma associated with DICER1 mutant: a case report and preclinical investigation.

Journal: Brain tumor pathology
Published: July 31, 2024

Multi-omics analysis identifies an M-MDSC-like immunosuppressive phenotype in lineage-switched AML with KMT2A rearrangement.

Multi-omics analysis identifies an M-MDSC-like immunosuppressive phenotype in lineage-switched AML with KMT2A rearrangement.

Journal: Nature communications
Published: July 10, 2024

KRAS G12 mutations as adverse prognostic factors in KMT2A-rearranged acute myeloid leukemia.

KRAS G12 mutations as adverse prognostic factors in KMT2A-rearranged acute myeloid leukemia.

Journal: Leukemia
Published: March 19, 2024

A Case of Myxoid Pleomorphic Liposarcoma with Rhabdoid Cells: A Diagnostic Pitfall.

A Case of Myxoid Pleomorphic Liposarcoma with Rhabdoid Cells: A Diagnostic Pitfall.

Journal: International journal of surgical pathology
Published: February 05, 2024

Haploidentical Hematopoietic Cell Transplantation With Post-Transplant Cyclophosphamide for Pediatric Chronic Active Epstein-Barr Virus Infection.

Haploidentical Hematopoietic Cell Transplantation With Post-Transplant Cyclophosphamide for Pediatric Chronic Active Epstein-Barr Virus Infection.

Journal: Pediatric transplantation
Published: November 13, 2023

High IL2RA/CD25 expression is a prognostic stem cell biomarker for pediatric acute myeloid leukemia without a core-binding factor.

High IL2RA/CD25 expression is a prognostic stem cell biomarker for pediatric acute myeloid leukemia without a core-binding factor.

Journal: Pediatric blood & cancer
Published: May 09, 2023

Droplet digital polymerase chain reaction assay for the detection of the minor clone of KIT D816V in paediatric acute myeloid leukaemia especially showing RUNX1-RUNX1T1 transcripts.

Droplet digital polymerase chain reaction assay for the detection of the minor clone of KIT D816V in paediatric acute myeloid leukaemia especially showing RUNX1-RUNX1T1 transcripts.

Journal: British journal of haematology
Published: March 18, 2021

High prevalence of SMARCB1 constitutional abnormalities including mosaicism in malignant rhabdoid tumors.

High prevalence of SMARCB1 constitutional abnormalities including mosaicism in malignant rhabdoid tumors.

Journal: European journal of human genetics : EJHG
Published: November 22, 2019
Showing 1-12 of 15

Last Updated: 09/26/2026